MitoQ

Re-engineered immune cells are the life and soul of the CAR T

Latest articles

Drive to end cancer could pioneer diagnostic technology

Blood test that can determine a cancer signal origin with high accuracy is now available on prescription in the US and could lead to...

Small is mighty when it comes to mitochondria supplements

Optimise, energise, revitalise – MitoQ is on a mission to supplement your mitochondrial health. Coenzyme Q10 – or CoQ10 – is made naturally in the...

Improving speed and accuracy in Alzheimer’s patients

Phase 2a study of patients with Alzheimer's or Parkinson's finds that ANVS401 treatment leads to significant improvement in speed and accuracy. Annovis Bio Inc, a...

New SIRT6 activator supplement hits the market

Sirtuin 6, the protein making waves in the longevity pool, can now be activated by a brand-new supplement. SIRT6 is a protein with an important...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...
fundraising

Editor's picks

Drive to end cancer could pioneer diagnostic technology

Blood test that can determine a cancer signal origin with high accuracy is now available on prescription in the US and could lead to...

Small is mighty when it comes to mitochondria supplements

Optimise, energise, revitalise – MitoQ is on a mission to supplement your mitochondrial health. Coenzyme Q10 – or CoQ10 – is made naturally in the...

Improving speed and accuracy in Alzheimer’s patients

Phase 2a study of patients with Alzheimer's or Parkinson's finds that ANVS401 treatment leads to significant improvement in speed and accuracy. Annovis Bio Inc, a...
MitoQ

Click the globe for translations.

Chimeric cells prove effective senolytic agents in targeting aging.

CAR T cells are being deployed against diseases caused by senescence with the hope that they could prove a successful therapy for fibrotic liver disease, atherosclerosis, diabetes and other debilitating conditions.

Longevity.Technology: Senescence is a tricky state of being – it promotes healing and deters cancer, but senescent cells that hang around and forget to die can cause chronic inflammation, which in turn causes disease. Being able to target and eliminate them when they tip over from helpfulness into harmfulness would be an important step in tackling aging.

Chimeric antigen receptor (CAR) T cells have had success as a therapy for cancers of the blood; the T cells are removed from an individual and then have their cancer cell targeting abilities enhanced before being returned to the body. Once back in place, the re-engineered immune cells strike with precision, seeking out and eliminating cancer cells.

While CAR T cells were originally programmed to target CD19, a molecule on the surface of blood cancers, a team at the Memorial Sloan Kettering Cancer Center have been been working to identify a target on the surface of senescent cells that could act as a homing beacon for the modified cells.

The research team identified a molecule, urokinase plasminogen activator receptor (uPAR), which is enriched on senescent cells but mostly absent on others. They were then able to engineer the CAR T cells to recognise uPAR.

In murine testing, the CAR T cells were able to eliminate senescent cells from liver fibrosis and improve survival in lung cancer cases when given alongside senescence-inducing drugs. In their paper on the research published in Nature this week, the team commented:  “…eliminating senescent cells from damaged tissues in mice ameliorates the symptoms of these pathologies and even promotes longevity [1].


“…this approach has the potential to tackle a number of senescence-related diseases for which new treatments are badly needed.”

 


 

Senior author on the paper, Dr Scott Lowe of the Cancer Biology & Genetics Program at the Sloan Kettering Institute, part of the MSKCC, said: “Cells in [a senescent] state play an important role in wound healing and cancer deterrence. But if they linger for too long, they can cause chronic inflammation, which itself is a cause of many diseases. Finding a way to safely eliminate these cells would be a major therapeutic breakthrough in the treatment of these diseases [2].”

The next stage in the research is to explore whether the uPAR-targeting CAR T cells can tackle other senescence-related diseases, including atherosclerosis, diabetes and osteoarthritis, and to develop the cells for clinical use in humans.

Dr Michael Sadelain, director of the Center for Cell Engineering at Memorial Sloan Kettering Cancer Center (MSKCC), where the first effective CAR T cells against cancer were pioneered, said: “This study demonstrates that T cell engineering and CAR therapy can be effective beyond cancer immunotherapy [3].”

Dr Lowe agrees: “We think this approach has the potential to tackle a number of senescence-related diseases for which new treatments are badly needed [4].”

[1] https://www.nature.com/articles/s41586-020-2403-9
[2] https://bit.ly/2YPDuhN
[3] Ibid
[4] Ibid

Image credit: By Roberto Sorin / Shutterstock
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
MitoQ

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
fundraising

Related articles

Improving speed and accuracy in Alzheimer’s patients

Phase 2a study of patients with Alzheimer's or Parkinson's finds that ANVS401 treatment leads to significant improvement in speed and accuracy. Annovis Bio Inc, a...

Brinter accelerates 3D bioprinting with €1.2m seed fund

Modular multi-material 3D bioprinting solution hopes to develop cost-effective answer to global need for kidney transplants. Turku-based bioprinting start-up Brinter has today announced the successful closure...

Occuity – shining a light on health and longevity

Forget windows to the soul, Occuity's non-invasive smart diagnostic tech provides a window to health and wellness. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited)...

Biogen wins FDA approval for Alzheimer’s drug aducanumab

Landmark decision means Alzheimer's research is moving past a bottleneck, with first new drug in 18 years. After two years of back-and-forth, the FDA has...

Research increases mice life expectancy by 30%

Bar-Ilan University researchers increase life expectancy in mice with protein SIRT6. The "fountain of youth" allows old mice to conduct the same level of...
MitoQ